NRX
$0.65
-
0.00%

NurExone Biologic Inc.
News & Events

Last updated: May 7, 2025, 5:14 PM ET

  1. NurExone Expands European Engagement with Investor Events in Germany and Switzerland

    GlobeNewswire MAY 2, 2025 4:05 PM EDT
    TORONTO and HAIFA, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (O...
    READ ARTICLE
  2. NurExone to Showcase Breakthrough in Facial Nerve Regeneration at ISEV 2025

    GlobeNewswire APR 24, 2025 4:15 PM EDT
    TORONTO and HAIFA, Israel, April 24, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) ...
    READ ARTICLE
  3. NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario

    GlobeNewswire APR 22, 2025 4:05 PM EDT
    TORONTO and HAIFA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) ...
    READ ARTICLE
  4. NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update

    GlobeNewswire APR 9, 2025 5:15 PM EDT
    TORONTO and HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) ...
    READ ARTICLE
  5. NurExone Biologic Announces U.S. Uplisting Intention and Closes C$2.3 Million Private Placement

    GlobeNewswire APR 4, 2025 9:16 AM EDT
    TORONTO and HAIFA, Israel, April 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: N...
    READ ARTICLE
  6. ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery

    GlobeNewswire MAR 14, 2025 4:03 PM EDT
    TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) ...
    READ ARTICLE
  7. NurExone Biologic Recognized as a 2025 TSX Venture 50(TM) Top Performing Stock

    Newsfile MAR 10, 2025 9:00 AM EDT
    Toronto, Ontario and Haifa, Israel--(Newsfile Corp. - March 10, 2025) - NurExone Biologic Inc. (T...
    READ ARTICLE
  8. NurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of NurExone Ophthalmology Project, to Receive Lifetime Achievement Award

    GlobeNewswire FEB 27, 2025 4:03 PM EST
    TORONTO and HAIFA, Israel, Feb. 27, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (...
    READ ARTICLE
  9. NurExone Biologic Recognized as a 2025 TSX Venture 50(TM) Top Performing Stock

    GlobeNewswire FEB 19, 2025 4:03 PM EST
    TORONTO and HAIFA, Israel, Feb. 19, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (...
    READ ARTICLE
  10. NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation

    GlobeNewswire FEB 14, 2025 4:03 PM EST
    TORONTO and HAIFA, Israel, Feb. 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (...
    READ ARTICLE

Upcoming Events

Get notified of NurExone Biologic Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available